Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A generous gift of £3.3million from the entrepreneur, private investor and philanthropist Mr André Hoffmann has secured the future of an Oxford Chair in Developmental Medicine.

Professor Georg Holländer, an expert in developmental biology and Head of the Department of Paediatrics at Oxford, currently holds the Chair. With this support, Professor Holländer will be able to advance our knowledge of how cells of the immune system grow and differentiate during foetal development and early life, resulting in the normal formation of our tissues and organs. This knowledge is vital in underpinning regenerative medicine, an area of scientific study that promises to transform patient care in the 21st century by reactivating cells to restore function after injury or disease.

Read the full story 

Similar stories

Children’s pain ‘swept under the carpet for too long’ – Lancet Commission

Neuroimaging Publication Research

The launch of Lancet Child and Adolescent Health Commission - the first ever to address paediatric pain - aims to raise the profile of children’s pain from early years to early adulthood.

Coronavirus: is it safe for children to return to school?

COVID-19 Children's Health General Parents & Carers

Stéphane Paulus and Else Bijker explore the topic in their article for The Conversation.

Oxford COVID-19 vaccine begins human trial stage

COVID-19 Recruitment Research Vaccinology

University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine.

Funding for new COVID-19 studies awarded to OVG's project on infectious disease immunity in children

Awards & Appointments COVID-19 Research Vaccinology

Five projects from across Oxford University's Medical Sciences Division, including a project led by Professor Matthew Snape from the Oxford Vaccine Group, are among twenty-one new studies into the novel coronavirus which have been funded by the UK government.

Visualising COVID-19 outbreak

COVID-19 Neuroimaging Research Research Methods

Paediatric Neuroimaging researcher provides real-time case information on epidemiological data from the COVID-19 outbreak.

Oxford COVID-19 vaccine programme opens for clinical trial recruitment

COVID-19 Research Vaccinology

University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19 have started screening healthy volunteers (aged 18-55) today for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won’t be ready for some weeks still.